DrugPatentWatch Database Preview
Details for Patent: 9,095,577
» See Plans and Pricing
Which drugs does patent 9,095,577 protect, and when does it expire?
Patent 9,095,577 protects ZUPLENZ and is included in one NDA.
Summary for Patent: 9,095,577
| Title: | Stabilized amine-containing actives in oral film compositions |
| Abstract: | The present invention relates to compositions relating to films containing active pharmaceutical agents. In particular, the present invention relates to methods and systems useful for stabilizing amine-containing actives for dispersion in a film product. |
| Inventor(s): | Myers; Garry L. (Kingsport, TN), Hariharan; Madhu Sudan (Munster, IN), Davidson; Kevin (Valparaiso, IN), Sanghvi; Pradeep (Dyer, IN) |
| Assignee: | MONOSOL RX, LLC (Warren, NJ) |
| Application Number: | 14/635,851 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Use; |
Drugs Protected by US Patent 9,095,577
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fortovia | ZUPLENZ | ondansetron | FILM;ORAL | 022524-001 | Jul 2, 2010 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Fortovia | ZUPLENZ | ondansetron | FILM;ORAL | 022524-002 | Jul 2, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
